$CBIO Income Statement | Understand Stock

$CBIO

$12.76 -$0.06 (0.47%) Close

$CBIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statement of operations and comprehensive loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue from collaboration and license agreements.
License revenue
Operating Expenses
Research and development
General and administrative
Restructuring and asset impairment charges
Total operating expenses
Loss from operations
Gain on sale of asset
Interest income
Total other income
Basic net loss per common share (in dollars per share)
Basic weighted-average number of common shares outstanding (in shares)
Other income (expense):
Interest income
Interest expense
Loss before provision for income taxes
Provision for income taxes
Net loss and comprehensive loss
Net loss per share attributable to ordinary shareholders, basic (in dollars per share)
Net loss per share attributable to ordinary shareholders, diluted (in dollars per share)
Net loss per share attributable to Series A non-voting convertible preferred shareholders, basic (in dollars per share)
Net loss per share attributable to Series A non-voting convertible preferred shareholders, diluted (in dollars per share)
Weighted-average ordinary shares outstanding used in computing net loss per share to ordinary shareholders, basic (in shares)
Weighted-average ordinary shares outstanding used in computing net loss per share to ordinary shareholders, diluted (in shares)
Weighted-average Series A non-voting convertible preferred shares outstanding used in computing net loss per share to Series A non-voting convertible preferred shareholders, basic (in shares)
Weighted-average Series A non-voting convertible preferred shares outstanding used in computing net loss per share to Series A non-voting convertible preferred shareholders, diluted (in shares)

Comments